Priya
Share
New Delhi: The series of quarterly results by companies is continuing. After the market opened today, pharma sector company Piramal Pharma released its July to September quarter results (Piramal Pharma Q2 Result). After the results released by the company, a huge surge was seen in its shares.
Piramal Pharma Q2 Result
Piramal Pharma said on Tuesday that the company's net profit in the September quarter was Rs 23 crore. Whereas, in the same quarter last year, the company's net profit was Rs 5 crore. If we talk about the company's revenue, then in the second quarter the company's revenue was Rs 2,242 crore, whereas in the same quarter last year it was Rs 1,911 crore.
He further added that to maintain this growth momentum, the company has announced a US$80 million expansion plan at its Lexington facility, which is expected to be completed by the end of FY 2027.
Current Status of Piramal Pharma Shares (Piramal Pharma Share)
After the release of the second quarter results, the company's shares are trading with tremendous growth today. At around 12.04 pm, the company's shares were trading at Rs 248.00 per share, up 14.44 percent or Rs 31.30. If we talk about the performance of the stock, it has given multibagger returns in the last one year. Yes, Piramal Pharma's shares have risen 170.81 percent in the last one year. At the same time, in the last six months, the company's stock has given a return of 78.13 percent.
According to the website of Bombay Stock Exchange (BSE), the M-Cap of Piramal Pharma is Rs 33,024.39 crore.
--Advertisement--
_118887027_124x80.jpg)
_326998179_124x80.png)
